28363-1-AP

antibody from Proteintech Group

Targeting: MAEA EMP, GID9, HLC-10, p44EMLP

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

28363-1-AP

Provider

Proteintech Group

Product name

MAEA antibody

Antibody type

Polyclonal

Description

MAEA antibody (Cat. #28363-1-AP) is a rabbit polyclonal antibody that shows reactivity with Human and has been validated for the following applications: IHC, WB,ELISA.

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Isotype

IgG

Vial size

20ul, 150ul

References

Submitted references

LAD1 promotes malignant progression by diminishing ubiquitin-dependent degradation of vimentin in gastric cancer.

Jiang Y, Feng Y, Huang J, Huang Z, Tan R, Li T, Chen Z, Tang X, Qiu J, Li C, Chen H, Yang Z
Journal of translational medicine 2023 Sep 17;21(1):632

---

Identifying E3 Ligase Substrates With Quantitative Degradation Proteomics.

Jordan VN, Ordureau A, An H
Chembiochem : a European journal of chemical biology 2023 Aug 15;24(16):e202300108

---

E3 ligase MAEA-mediated ubiquitination and degradation of PHD3 promotes glioblastoma progression.

Zhou P, Peng X, Tang S, Zhang K, Tan Z, Li D, Shen L, Peng J, Yang L
Oncogene 2023 Apr;42(16):1308-1320

---

Oncopeptide MBOP Encoded by LINC01234 Promotes Colorectal Cancer through MAPK Signaling Pathway.

Tang C, Zhou Y, Sun W, Hu H, Liu Y, Chen L, Ou F, Zeng S, Lin N, Yu L
Cancers 2022 May 9;14(9)